Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$2.17 USD
-0.28 (-11.43%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.17 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Aptevo Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
APVO 2.17 -0.28(-11.43%)
Will APVO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APVO
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year?
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's What You Should Know
APVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for APVO
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Aptevo Therapeutics (APVO) Schedules Offering of 8.25 Million Shares
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
12 Health Care Stocks Moving In Friday's Intraday Session